Same Indication

Nivolumab vs Valproic Acid

Nivolumab vs Valproic Acid: Overview

This comparison examines the pharmacological differences between Nivolumab and Valproic Acid.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Valproic Acid: Enhances GABA transmission and blocks sodium/calcium channels.

Pharmacokinetics

Half-life: Nivolumab β€” 27 days; Valproic Acid β€” 9-16 hours.

Chemical Properties

Molecular Formula: Valproic Acid β€” C8H16O2.

Molecular Weight: Valproic Acid β€” 144.2110 g/mol.

Type: Nivolumab β€” Antibody; Valproic Acid β€” Small molecule.